|
National Stock Number(NSN): 6505-01-101-5361 (6505011015361, 011015361)
| NIIN: |
01-101-5361 |
Item Name: |
MULTIVITAMIN SOLUTION FOR INJECTION |
INC: |
32581
|
| FSC: |
6505
|
Assignment Date: |
Oct-02-1980 |
CRIT: |
X |
IIG: |
32581 |
| ISC: |
5 |
Date Standardized: |
Oct-02-1980 |
HMIC: |
P |
DODIC: |
|
| NSC: |
4 |
Cancellation Date: |
Oct-22-2024 |
PMIC: |
U |
FIIG: |
A45100 |
| ESD: |
|
Schedule B: |
3004.50.5040 |
DEMIL: |
A |
DEMIL INT: |
1 |
| TIIC: |
1 |
Originator: |
97 |
ADPEC: |
|
RPDMRC: |
|
| Part Number |
CAGE |
Company |
Status |
RN CC |
RN VC |
DAC |
RN AAC |
RN FC |
RN SC |
RN JC |
SADC |
HCC |
MSDS |
|
119-931 |
04689
|
USV PHARMACEUTICAL CORP DIV OF WILLIAM H RORER INC |
H |
3 |
2 |
6 |
54 |
4 |
D |
|
|
|
|
|
M. V. I.-12 |
04689
|
USV PHARMACEUTICAL CORP DIV OF WILLIAM H RORER INC |
H |
5 |
9 |
6 |
54 |
4 |
B |
|
|
|
|
|
NDC00075-0812-31 |
04689
|
USV PHARMACEUTICAL CORP DIV OF WILLIAM H RORER INC |
H |
3 |
2 |
6 |
54 |
1 |
D |
|
|
|
|
Technical Characteristics Information
| MRC |
Requirement Statement |
Reply Statement |
| AKJA |
ACTIVE MEDICAMENT MEDICINAL STRENGTH |
20.000 MILLIGRAMS ASCORBIC ACID PER MILLILITER AND 12.000 MICROGRAMS BIOTIN PER MILLILITER AND 1.000 MICROGRAMS CYANOCOBALAMIN PER MILLILITER AND 3.000 MILLIGRAMS DEXPANTHENOL PER MILLILITER AND 2.000 INTERNATIONAL UNITS DL-ALPHA-TOCOPHERYL ACETATE PER MILLILITER AND 40.000 INTERNATIONAL UNITS ERGOCALCIFEROL PER MILLILITER AND 80.000 MICROGRAMS FOLIC ACID PER MILLILITER AND 8.000 MILLIGRAMS NIACINAMIDE PER MILLILITER AND 0.800 MILLIGRAMS PYRIDOXINE HYDROCHLORIDE PER MILLILITER AND 660.000 INTERNATIONAL UNITS RETINOL PER MILLILITER AND 0.720 MILLIGRAMS RIBOFLAVIN PER MILLILITER AND 0.600 MILLIGRAMS THIAMINE PER MILLILITER |
| AKJQ |
PHARMACEUTICAL VEHICLE TYPE |
AQUEOUS |
| CBBL |
FEATURES PROVIDED |
STERILE |
| CQCT |
PRIMARY CONTAINER TYPE |
BOTTLE |
| CQGK |
SECONDARY CONTAINER TYPE |
PACKAGE |
| CRLK |
PRIMARY CONTAINER CONTENT QUANTITY |
5.000 MILLILITERS |
| CRXL |
PRIMARY CONTAINER QUANTITY PER SECONDARY CONTAINER |
2 BOTTLE |
| CSCW |
TOTAL PRIMARY CONTAINER QUANTITY |
50 |
| CSCX |
TOTAL SECONDARY CONTAINER QUANTITY |
25 |
| CSGS |
ADMINISTRATION |
INTRAVENOUS INFUSION |
| FEAT |
SPECIAL FEATURES |
EACH PACKAGE CONSISTS OF 2 VIALS LABELED VIAL 1 AND VIAL 2; EACH VIAL CONTAINS A PH ADJUSTOR |
| MOE Rule |
Former MOER |
Effective |
AMC |
AMSC |
IMC |
IMCA |
Collaborators |
Receivers |
| V540 |
|
Apr-01-1991 |
0 |
0 |
|
|
54 |
54 |
|